Skip to content

The NEMO Project

Longitudinal Monitoring of Neuropsychological Outcomes in Pediatric Oncology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON21245
Enrollment
320
Registered
2021-01-26
Start date
2021-06-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropsychological deficits as a consequence of childhood cancer Neurospychological monitoring, cognitive deficits, pediatric cancer

Interventions

None listed

Sponsors

The Princess Máxima Centre
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: • New primary diagnosis of brain tumor, other solid tumor, or hemato-oncological condition • Age between 6 and 18 years old at diagnosis • Followed at the Princess Máxima Centre for Pediatric Oncology

Exclusion criteria

Exclusion criteria: • No signed informed consent • Insufficient knowledge of the Dutch language to perform the neuropsychological assessment or complete questionnaires • Significant visual, motor, or developmental problems and thus alternative neuropsychological assessments would be needed (i.e., blindness, deafness, profound developmental delay) • Patients receiving palliative therapy or end-of-life care • Treating physician advises against inclusion

Design outcomes

Primary

MeasureTime frame
Age-standardized performance on functional outcome measures (intelligence, memory, academics, school functioning, adaptive functioning, social-emotional functioning) and broader aspects of neuropsychological functioning (attention, executive function, working memory, processing speed, visual-spatial/motor, quality of life)

Secondary

MeasureTime frame
Secondary and tertiary study parameters/endpoints: Longitudinal trajectories on brief monitoring measures (1), clinical, biological, and psychosocial risk factors (2), mean performance and frequency of impairments on neuropsychological measures (3), and acceptability and feasibility of a monitoring program (4).

Contacts

Public ContactMarisa Huisman

Prinses Maxima Centrum

m.h.huisman-13@prinsesmaximacentrum.nl06-50173090

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)